We found that diffuse symmetric CYP11B2 positivity (10.4% of individuals) and APMs ≥20 (19.6% of individuals) were not associated with significant CV pathology at autopsy or the risk of DSD. This evidence concerns the gene CYP11B2 and disorder of sexual differentiation.